Somewhat Positive News Coverage Somewhat Unlikely to Impact Dolby Laboratories (DLB) Share Price

News headlines about Dolby Laboratories (NYSE:DLB) have been trending somewhat positive on Wednesday, according to Accern Sentiment. Accern identifies positive and negative news coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Dolby Laboratories earned a news impact score of 0.08 on Accern’s scale. Accern also gave media stories about the electronics maker an impact score of 45.5351134724256 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.

These are some of the news headlines that may have effected Accern Sentiment Analysis’s analysis:

Shares of Dolby Laboratories (NYSE DLB) traded down $0.59 during trading on Wednesday, hitting $61.30. The stock had a trading volume of 218,800 shares, compared to its average volume of 380,410. Dolby Laboratories has a 12-month low of $44.98 and a 12-month high of $63.34. The company has a market cap of $6,330.60, a price-to-earnings ratio of 29.75, a PEG ratio of 2.30 and a beta of 0.86.

Dolby Laboratories (NYSE:DLB) last released its earnings results on Wednesday, October 25th. The electronics maker reported $0.45 EPS for the quarter, beating the Zacks’ consensus estimate of $0.27 by $0.18. The company had revenue of $242.05 million during the quarter, compared to analysts’ expectations of $244.80 million. Dolby Laboratories had a return on equity of 10.62% and a net margin of 18.66%. The firm’s revenue for the quarter was up 3.9% compared to the same quarter last year. During the same quarter last year, the business posted $0.37 EPS. equities analysts anticipate that Dolby Laboratories will post 2.24 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which was paid on Wednesday, November 15th. Shareholders of record on Monday, November 6th were issued a $0.16 dividend. This is a positive change from Dolby Laboratories’s previous quarterly dividend of $0.14. The ex-dividend date was Friday, November 3rd. This represents a $0.64 dividend on an annualized basis and a dividend yield of 1.04%. Dolby Laboratories’s dividend payout ratio (DPR) is presently 32.99%.

Several brokerages have issued reports on DLB. B. Riley reissued a “buy” rating and issued a $65.50 price target on shares of Dolby Laboratories in a research note on Thursday, October 26th. BidaskClub lowered Dolby Laboratories from a “sell” rating to a “strong sell” rating in a research report on Tuesday, August 22nd. Dougherty & Co reiterated a “buy” rating and set a $63.00 price target on shares of Dolby Laboratories in a report on Wednesday, September 13th. Piper Jaffray Companies restated a “hold” rating and issued a $52.00 price objective (up previously from $49.00) on shares of Dolby Laboratories in a research note on Wednesday, September 13th. Finally, Zacks Investment Research cut Dolby Laboratories from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, October 31st. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and two have issued a buy rating to the company. The stock currently has an average rating of “Hold” and a consensus target price of $60.17.

In other Dolby Laboratories news, CMO Bob Borchers sold 50,000 shares of the business’s stock in a transaction dated Tuesday, November 28th. The stock was sold at an average price of $62.72, for a total transaction of $3,136,000.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CFO Lewis Chew sold 17,000 shares of the business’s stock in a transaction dated Friday, November 10th. The stock was sold at an average price of $59.55, for a total value of $1,012,350.00. The disclosure for this sale can be found here. In the last three months, insiders sold 511,095 shares of company stock valued at $31,288,813. Corporate insiders own 43.80% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: This report was published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this report on another site, it was copied illegally and reposted in violation of United States & international copyright law. The correct version of this report can be viewed at https://www.dispatchtribunal.com/2017/12/13/dolby-laboratories-dlb-receives-coverage-optimism-score-of-0-08.html.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc designs and manufactures audio and imaging products for the cinema, television, broadcast and entertainment industries. Its products for cinema include Digital Cinema Servers and Cinema Audio Products, and broadcast and other include Dolby Conference Phone and Other Products. It offers services to support theatrical and television production for cinema exhibition, broadcast and home entertainment, including equipment training and maintenance, mixing room alignment and equalization, as well as audio, color and light image calibration.

Insider Buying and Selling by Quarter for Dolby Laboratories (NYSE:DLB)

Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply